UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 

FORM 8-K
 
CURRENT REPORT
Pursuant To Section 13 Or 15(d) of The Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  December 7, 2011
 
CVS CAREMARK CORPORATION
(Exact name of registrant
as specified in charter)
     
     
 
Delaware
001-01011
05-0494040
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
One CVS Drive, Woonsocket, Rhode Island 02895
(Address of principal executive offices)
 
     
Registrant’s telephone number, including area code:  (401) 765-1500
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 8.01. 
Other Events.

On December 7, 2011, CVS Caremark Corporation, a Delaware corporation (the “Company”), issued a press release announcing the expiration and final results of its tender offer for any and all of its 6.302% Enhanced Capital Advantaged Preferred Securities.  A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01    
Financial Statements and Exhibits

(d)  Exhibits
 
 
Exhibit  No. 
Description

99.1 
Press release, dated December 7, 2011, of CVS Caremark Corporation

 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
CVS CAREMARK CORPORATION
  
       
Date:
December 7, 2011
  
By:
/s/ David M. Denton
  
       
Name:
David M. Denton
  
       
Title:
Executive Vice President and Chief Financial Officer